Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Hui Liu

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
Journal of Molecular Biology|May 1, 2012
Generating bispecific human IgG1 and IgG2 antibodies from any antibody pairPavel Strop, Wei-Hsien Ho, Leila M Boustany, et al.
Science Signaling|March 31, 2016
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitorsSizhi P Gao, Qing Chang, Ninghui Mao, et al.
Blood Advances|January 4, 2018
A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignanciesShu-Hui Liu, Yin Gu, Bernadette Pascual, et al.
Chemistry & Biology|February 27, 2013
Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugatesPavel Strop, Shu-Hui Liu, Magdalena Dorywalska, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
Nature Biotechnology|July 9, 2015
Site-specific conjugation improves therapeutic index of antibody drug conjugates with high drug loadingPavel Strop, Kathy Delaria, Davide Foletti, et al.
Journal of Molecular Biology|May 1, 2012
Generating bispecific human IgG1 and IgG2 antibodies from any antibody pairPavel Strop, Wei-Hsien Ho, Leila M Boustany, et al.
Science Signaling|March 31, 2016
JAK2 inhibition sensitizes resistant EGFR-mutant lung adenocarcinoma to tyrosine kinase inhibitorsSizhi P Gao, Qing Chang, Ninghui Mao, et al.
Blood Advances|January 4, 2018
A novel CXCR4 antagonist IgG1 antibody (PF-06747143) for the treatment of hematologic malignanciesShu-Hui Liu, Yin Gu, Bernadette Pascual, et al.
Chemistry & Biology|February 27, 2013
Location matters: site of conjugation modulates stability and pharmacokinetics of antibody drug conjugatesPavel Strop, Shu-Hui Liu, Magdalena Dorywalska, et al.
Pageof 9